UCB SA Partners with Domino Data Lab to Modernize Statistical Computing for Faster Drug Development

Reuters
05/20
UCB SA Partners with Domino Data Lab to Modernize Statistical Computing for Faster Drug Development

UCB SA has announced a new partnership with Domino Data Lab to modernize its Statistical Computing Environment $(SCE.UK)$ and advance the development of innovative therapies for severe diseases. This collaboration aims to enhance UCB's research capabilities by integrating diverse analytical tools like SAS, R, and Python within a cloud-enabled framework, leveraging Domino's cloud technologies and open-source support. The partnership will also focus on fostering open-source principles and establishing global standards for efficient and compliant statistical environments, contributing to initiatives like PHUSE and the SCE Coalition. UCB's broader scientific innovation strategy aligns with this effort to accelerate clinical development and maintain compliance with industry standards such as GxP, FDA 21 CFR Part 11, and GDPR.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UCB SA published the original content used to generate this news brief via PR Newswire (Ref. ID: SF90445) on May 19, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10